indications for glp 1 agonist The science on GLP-1 receptor agonists has outpaced the public narrative. While headlines chase the latest prescription numbers, evidence-based practice demands we hold the line: obesity is a chronic, relapsing condition; not 🚀 GLP-1 receptor agonists (GLP-1RAs)

doi: 10.1161/JAHA.113.000542

AGEs are final, permanent products of glycation that can modify the physicochemical properties of proteins, increase their resistance to proteolysis, and interact with RAGE receptors, causing oxidative stress and an inflammatory response 57

B12 interactions with other medications are also a consideration

Medication name: * Tri Bedoyecta Comparable patent medicine: Bedoyecta * Tri Active ingredient: hydroxocobalamin (vitamin B12), Thiamine (Vit B1), Pyridoxine (Vit B6) Presentation: Solution for Injection Concentration: 10.000 mg/100 mg/50 mg Extended-release tablets: No Lab: Grossman, S